The XIa Factor: Insights on Reducing Stroke Recurrence with Dual-Pathway and Novel Antithrombotic Approaches
Please note: your participation will not show as ‘Completed’ on ASHP’s website.
Your statement of participation will be saved on the PVI, PeerView Institute for Medical Education website.
Please note: The content for this activity is hosted on another CE Provider’s site.
This PeerView activity examines the critical role of dual-pathway and novel antithrombotic approaches for secondary stroke prevention. Through an interactive Q&A format, explore insights into which patients are at high risk for stroke recurrence and how factor XI/factor IXa (FXI/FXIa) inhibition can help. You’ll also gain clarity on the latest clinical evidence for FXI/FXIa inhibitors in the prevention of ischemic stroke recurrence in those without atrial fibrillation and how to incorporate team-based approaches into real-world scenarios. Test your knowledge and skills with this self-paced educational opportunity!
Credit Designation: 0.75 CME/CPE/IPCE
Learning Objectives:
• Describe risk factors and clinical circumstances that place patients at high risk for recurrent stroke events
• Determine unmet clinical needs among patients at risk to suffer from recurrent non-cardioembolic ischemic stroke events, guiding the mechanistic rationale for factor XI/factor XIa (FXI/FXIa) inhibition
• Evaluate emerging clinical evidence on the efficacy and safety of FXI/FXIa inhibitors for secondary prevention of ischemic stroke recurrence in patients without atrial fibrillation
• Design evidence-informed, collaborative treatment approaches that incorporate FXI/FXIa inhibition strategies within the evolving paradigms of secondary stroke prevention
Questions/Comments concerning this activity should be directed to info@peerview.com.